STOCK TITAN

Amesite (AMST) CFO receives 2,500 stock options at $3.05 exercise price

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Amesite Inc. chief financial officer Sarah Berman reported a compensation-related stock option grant. She received options to buy 2,500 shares of common stock at an exercise price of $3.05 per share, expiring on May 22, 2035. According to the vesting terms under the 2018 Equity Incentive Plan, 25% of the shares vest on May 22, 2026, with the remaining shares vesting in equal monthly installments over 36 months.

Positive

  • None.

Negative

  • None.
Insider Berman Sarah
Role CHIEF FINANCIAL OFFICER
Type Security Shares Price Value
Grant/Award Stock Option (right to buy) 2,500 $0.00 --
Holdings After Transaction: Stock Option (right to buy) — 2,500 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Options granted 2,500 options Stock Option (right to buy) grant on May 22, 2025
Exercise price $3.05 per share Exercise price for options to buy Amesite common stock
Underlying shares 2,500 shares Common stock underlying the option grant
Expiration date May 22, 2035 Option expiration under the 2018 Equity Incentive Plan
Initial vesting 25% on May 22, 2026 First tranche of options vesting
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
2018 Equity Incentive Plan financial
"The option was issued pursuant to the Issuer's 2018 Equity Incentive Plan."
vested financial
"Twenty-five percent (25%) of the shares subject to the option vested on May 22, 2026"
underlying security financial
"underlying_security_title: Common Stock"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Berman Sarah

(Last)(First)(Middle)
C/O AMESITE INC
607 SHELBY STREET, SUITE 700 PMB 214

(Street)
DETROIT MICHIGAN 48226

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Amesite Inc. [ AMST ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CHIEF FINANCIAL OFFICER
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/22/2025
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$3.0505/22/2025A2,500 (1)05/22/2035Common Stock2,500$02,500D
Explanation of Responses:
1. The option was issued pursuant to the Issuer's 2018 Equity Incentive Plan. Twenty-five percent (25%) of the shares subject to the option vested on May 22, 2026, with one thirty-sixth (1/36th) of the remaining shares subject to the option vesting monthly thereafter.
/s/ Sarah Berman07/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Amesite (AMST) CFO Sarah Berman report in this Form 4 filing?

Amesite CFO Sarah Berman reported receiving a grant of stock options. The award covers 2,500 options to purchase Amesite common stock, issued under the 2018 Equity Incentive Plan with a defined vesting schedule and a $3.05 per share exercise price.

How many Amesite (AMST) stock options were granted to the CFO?

The CFO received 2,500 stock options. Each option represents the right to buy one share of Amesite common stock, giving her the ability to purchase up to 2,500 shares if the options vest and are exercised in the future.

What is the exercise price and expiration date of the Amesite (AMST) CFO’s options?

The options have an exercise price of $3.05 per share and expire on May 22, 2035. This means the CFO can buy shares at $3.05, if vested, any time before the May 2035 expiration date.

How do the Amesite (AMST) CFO stock options vest over time?

Twenty-five percent of the options vest on May 22, 2026, with the remaining shares vesting monthly in 1/36 increments. This creates a multi-year vesting schedule that encourages continued service with Amesite under the 2018 Equity Incentive Plan.

Is the Amesite (AMST) CFO’s Form 4 transaction an open-market stock purchase?

No, this Form 4 reflects a grant of stock options, not an open-market purchase. The options were issued at no cost as compensation, with a $3.05 per share exercise price if the CFO chooses to exercise vested options later.